VanEck Genomics and Healthcare Innovators UCITS ETF
CURE.DE
#3262
ETF rank
ยฃ10.29 M
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
ยฃ15.59
Share price
-1.12%
Change (1 day)
7.10%
Change (1 year)

Expense ratio and fees for VanEck Genomics and Healthcare Innovators UCITS ETF (CURE.DE)

Total Expense Ratio

Total Expense Ratio as of June 2026: 0.35%